Agustin Melian

Statistics

Publications

Citations

683

H-Index

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Agustin Melian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and clinical pharmacology.

Publications per year

2002–2015

Publications

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia

Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 265 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +16

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty‐two–week, randomized, controlled study

Désirée van der Heijde, Herbert S. B. Baraf, César Ramos-Remus et al. · Arthritis & Rheumatism · 2005 · 232 citations

Medicine, Pharmacology, Pharmacotherapy +13

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]

Eduardo Collantes‐Estévez, Sean Curtis, Ka Wing Lee et al. · BMC Family Practice · 2002 · 109 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy

Christos Tsoukas, M. Elaine Eyster, Sumiko Shingo et al. · Blood · 2005 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial

Alan K. Matsumoto, Agustin Melian, Arvind Shah et al. · Current Medical Research and Opinion · 2007 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 6